Comparison of cytogenetic and molecular responses between the nilotinib arm and the dasatinib arm. Cumulative achievement rates of CCyR (A), MMR (B), MR^4.0 (C), and MR^4.5 (D) by 12, 18, 24, and 36 months. The results were calculated on the ITT population by means of the CMH test. ∗Primary end point and same as Figure 2B.